TESARO
Founded in 2010, TESARO is a privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to leverage the experience and competencies of its management team to identify, acquire and develop promising drug candidates; and to commercialize safer and more effective products for the treatment and support of cancer patients. TESARO is developing rolapitant, a potent, selective neurokinin-1 receptor antagonist that has completed P... hase 2 clinical testing for the prevention of chemotherapy induced nausea and vomiting, and is advancing its ALK inhibitor program for oncology indications. Phase 3 clinical testing of rolapitant is planned to commence during 2011 and the first ALK inhibitor clinical trial is targeted to begin in 2012. TESARO was co-founded by former executives of MGI PHARMA, an oncology and acute-care focused biopharmaceutical company that Eisai Co., Ltd. acquired in 2008 for $3.9 billion. TESARO is headquartered in Waltham, Massachusetts.
TESARO
Industry:
Biopharma Biotechnology Health Care
Founded:
2010-03-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.tesarobio.com
Total Employee:
101+
Status:
Closed
Contact:
339.970.0900
Email Addresses:
[email protected]
Total Funding:
407 M USD
Technology used in webpage:
SPF LetsEncrypt Domain Not Resolving Mobile Non Scaleable Content Amazon IPv6 Microsoft Azure DNS PHP 7 ASP.NET IIS
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Ally Bridge Group
Ally Bridge Group investment in Post-IPO Equity - TESARO
Johnson & Johnson
Johnson & Johnson investment in Post-IPO Equity - TESARO
InterWest Partners
InterWest Partners investment in Post-IPO Equity - TESARO
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - TESARO
Kleiner Perkins
Kleiner Perkins investment in Post-IPO Equity - TESARO
Future Fund
Future Fund investment in Post-IPO Equity - TESARO
Sofinnova Investments
Sofinnova Investments investment in Series C - TESARO
New Enterprise Associates
New Enterprise Associates investment in Series B - TESARO
Pappas Ventures
Pappas Ventures investment in Series B - TESARO
Oracle Capital Partners
Oracle Capital Partners investment in Series B - TESARO
Newest Events participated
Official Site Inspections
http://www.tesarobio.com
- Host name: 158.246.120.34.bc.googleusercontent.com
- IP address: 34.120.246.158
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
